Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan-fludarabine vs Thiotepa-fludarabine RIC for Myelofibrosis
NCT01814475Phase 2Completed
- Sponsor
- GITMO
- Start
- Jul 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in myelofibrosis (MF), sponsored by GITMO. Started Jul 2011; status: completed.
02
Drugs
thiotepa
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01814475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814475.